In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 107.1 | 95.6 | 90.7 | 85.5 | 71.2 | 63.2 | 57.4 | 52.6 |
Interest income on investments | 16.1 | 11.4 | 9.3 | 12.1 | 13.1 | 9.5 | 7.5 | 7.5 |
Interest income on repurchase agreements | 0.2 | 0.3 | 0.3 | 1.1 | 0.5 | 0.3 | 0.1 | 0.1 |
| 123.3 | 107.3 | 100.2 | 98.7 | 84.8 | 73.0 | 65.0 | 60.1 |
Interest expense: |
Interest on deposits | 22.6 | 7.9 | 11.3 | 25.2 | 17.1 | 7.6 | 3.4 | 2.2 |
Interest on borrowings | 2.7 | 2.9 | 4.7 | 5.1 | 3.7 | 3.8 | 3.6 | 2.8 |
| 31.6 | 12.2 | 17.4 | 32.2 | 22.7 | 13.0 | 7.9 | 6.0 |
Net interest income | 91.7 | 95.1 | 82.8 | 66.4 | 62.1 | 60.1 | 57.1 | 54.2 |
Provision for loan losses | 2.5 | 1.5 | -12.0 | -0.6 | -0.3 | | 1.0 | 0.9 |
Net interest income after provision for loan losses | 89.2 | 93.6 | 94.8 | 67.0 | 62.3 | 60.1 | 56.1 | 53.3 |
Deposit and loan fees | | | | | | | | 2.6 |
Other non-interest income | 10.2 | 9.7 | 9.6 | 8.3 | 7.8 | 8.6 | 8.0 | 5.6 |
Total non-interest income | 10.2 | 9.7 | 9.6 | 8.3 | 7.8 | 8.6 | 8.0 | 8.2 |
Non-interest expenses | 45.1 | 43.4 | 39.1 | 38.4 | 35.0 | 32.3 | 31.1 | 30.1 |
Asset impairment | | | | | 0.3 | | | |
Pre-tax income | 59.4 | 62.9 | 41.4 | 35.7 | 35.1 | 36.4 | 33.0 | 31.4 |
Income taxes | 13.0 | 13.3 | 8.7 | 7.1 | 6.6 | 13.4 | 9.9 | 9.7 |
Tax rate | 21.9% | 21.1% | 20.9% | 19.7% | 18.7% | 36.7% | 30.2% | 30.8% |
Net income | 46.4 | 49.6 | 32.7 | 28.7 | 28.5 | 23.1 | 23.0 | 21.7 |
Net margin | 46.7% | 48.0% | 31.3% | 38.1% | 40.7% | 33.6% | 35.9% | 35.3% |
|
Basic EPS | $2.79 | $3.00 | $1.99 | $1.75 | $1.75 | $1.42 | $1.43 | $1.35 |
Diluted EPS | $2.76 | $2.95 | $1.98 | $1.74 | $1.74 | $1.41 | $1.42 | $1.35 |
|
Shares outstanding (basic) | 16.6 | 16.5 | 16.4 | 16.4 | 16.3 | 16.2 | 16.1 | 16.1 |
Shares outstanding (diluted) | 16.8 | 16.8 | 16.5 | 16.5 | 16.4 | 16.3 | 16.2 | 16.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |